The company has substantially improved its progress of an novel solution for ATTR-CM, leveraging the compound. Preliminary patient data indicates significant improvements for patients affected from this severe illness. https://biotech058551.ltfblog.com/40520234/company-progresses-attr-cm-management-through-attruby